These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5549140)

  • 21. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
    Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between arterial oxygen tension and serum aminotransferases in morbidly obese patients with fatty liver.
    Nanji AA; French SW; Freeman JB
    Clin Chem; 1985 Sep; 31(9):1571-2. PubMed ID: 4028411
    [No Abstract]   [Full Text] [Related]  

  • 24. [Observation on therapeutic effect of acupuncture for treatment of patients with nonalcoholic steatohepatitis].
    Meng SX
    Zhongguo Zhen Jiu; 2009 Aug; 29(8):616-8. PubMed ID: 19947262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver enzymes, fatty liver and type 2 diabetes.
    Neely D
    Ann Clin Biochem; 2005 May; 42(Pt 3):167-9. PubMed ID: 15949150
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies of alcoholic damage to the liver with special reference to stimulation of serum transaminase activity].
    Takada A; Kanayama R; Ohara N; Sawae G; Hirose S
    Saishin Igaku; 1968 Jun; 23(6):1283-97. PubMed ID: 5703158
    [No Abstract]   [Full Text] [Related]  

  • 27. Declining frequency of liver enzyme abnormalities with statins: experience from general practice in Jerusalem.
    Kiderman A; Ben-Dov IZ; Glikberg F; Ackerman Z
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1002-5. PubMed ID: 18787468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Catarrhal hepatosis or acute fatty liver?].
    Meyer zu Schwabedissen O
    Med Klin; 1967 Sep; 62(37):1419-21. PubMed ID: 5593031
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
    Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
    Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the accuracy of laboratory tests in the diagnosis of fatty liver].
    Kaffarnik H; Gross W; Juchems R
    Munch Med Wochenschr; 1967 Jan; 109(4):199-200. PubMed ID: 6071799
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver involvement in ulcerative colitis].
    Hornik J
    Z Arztl Fortbild (Jena); 1969 Apr; 63(7):383-5. PubMed ID: 5787544
    [No Abstract]   [Full Text] [Related]  

  • 34. The prevalence and etiology of elevated aminotransferase levels in the United States.
    Clark JM; Brancati FL; Diehl AM
    Am J Gastroenterol; 2003 May; 98(5):960-7. PubMed ID: 12809815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms of adaptation of phosphorus energy metabolism in the liver in acute cholecystitits].
    Kovalev MM; Bezrodnyĭ BG
    Vrach Delo; 1980 Aug; (8):26-9. PubMed ID: 6447947
    [No Abstract]   [Full Text] [Related]  

  • 36. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
    J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.
    Sonsuz A; Basaranoglu M; Ozbay G
    Am J Gastroenterol; 2000 May; 95(5):1370-1. PubMed ID: 10811364
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of chenodesoxycholic acid on serum lipids and enzymes (transaminases) in patients with biliary lithiasis].
    Bataller Sifre R; Pascual Bataller E; Rosique Martínez A; Miralles Espi MC
    Rev Esp Enferm Apar Dig; 1982 Feb; 61(2):141-4. PubMed ID: 7089362
    [No Abstract]   [Full Text] [Related]  

  • 39. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.
    Yilmaz Y; Ulukaya E; Dolar E
    Hepatology; 2009 Feb; 49(2):697; author reply 697. PubMed ID: 19035337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.